![Heidi Hagen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heidi Hagen
Directeur/Membre du Conseil chez VERICEL CORPORATION
Fortune : 889 605 $ au 31/05/2024
Postes actifs de Heidi Hagen
Sociétés | Poste | Début | Fin |
---|---|---|---|
VERICEL CORPORATION | Directeur/Membre du Conseil | 23/08/2013 | - |
Independent Dir/Board Member | 23/08/2013 | - | |
Obsidian Therapeutics, Inc.
![]() Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
A-Alpha Bio, Inc.
![]() A-Alpha Bio, Inc. Packaged SoftwareTechnology Services A-Alpha Bio, Inc. designs and develops a drug discovery platform. The firm offers AlphaSeq platform. The company was founded by Randolph Lopez and David Younger in 2017 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 27/06/2023 | - |
Independent Dir/Board Member | 27/06/2023 | - |
Historique de carrière de Heidi Hagen
Anciens postes connus de Heidi Hagen
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALAUNOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/06/2019 | 02/11/2021 |
Directeur Général | 25/02/2021 | 30/08/2021 | |
Independent Dir/Board Member | 30/08/2021 | 02/11/2021 | |
Vineti, Inc.
![]() Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Directeur/Membre du Conseil | - | 01/02/2021 |
Directeur des opérations | - | - | |
Fondateur | - | 01/02/2021 | |
Corporate Officer/Principal | 01/10/2015 | 01/02/2021 | |
ZappRx, Inc.
![]() ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Directeur des opérations | 01/01/2015 | 01/06/2015 |
Sotio LLC | Directeur des opérations | 01/03/2013 | 01/04/2014 |
DENDREON CORPORATION | Directeur des opérations | 01/10/2002 | 01/05/2012 |
Sotio Biotech AS
![]() Sotio Biotech AS BiotechnologyHealth Technology SOTIO Biotech AS is a company based in Prague, Czechia. The Czech company is focused on developing potent immunotherapies for cancer patients. The company's pipeline includes three clinical-stage programs: SOT102, a next-generation claudin-18.2-targeted antibody-drug conjugate; BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting GPC3-expressing tumors; and SOT201, a next-generation PD-1-targeting immunocytokine. SOTIO Biotech is a member of the PPF Group. Radek Špíšek has been the CEO of the company since 2010. | Directeur des opérations | - | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Heidi Hagen
University of Washington | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
République Tchèque | 2 |
Opérationnelle
Director/Board Member | 6 |
Chief Operating Officer | 5 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 7 |
Consumer Services | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
VERICEL CORPORATION | Health Technology |
ALAUNOS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Sotio LLC | |
Vineti, Inc.
![]() Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Health Services |
Dendreon Corp.
![]() Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
ZappRx, Inc.
![]() ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Commercial Services |
Lykan Biosciences LLC | |
Obsidian Therapeutics, Inc.
![]() Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Sonoma Biotherapeutics, Inc.
![]() Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
Sotio Biotech AS
![]() Sotio Biotech AS BiotechnologyHealth Technology SOTIO Biotech AS is a company based in Prague, Czechia. The Czech company is focused on developing potent immunotherapies for cancer patients. The company's pipeline includes three clinical-stage programs: SOT102, a next-generation claudin-18.2-targeted antibody-drug conjugate; BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting GPC3-expressing tumors; and SOT201, a next-generation PD-1-targeting immunocytokine. SOTIO Biotech is a member of the PPF Group. Radek Špíšek has been the CEO of the company since 2010. | Health Technology |
A-Alpha Bio, Inc.
![]() A-Alpha Bio, Inc. Packaged SoftwareTechnology Services A-Alpha Bio, Inc. designs and develops a drug discovery platform. The firm offers AlphaSeq platform. The company was founded by Randolph Lopez and David Younger in 2017 and is headquartered in Seattle, WA. | Technology Services |
- Bourse
- Insiders
- Heidi Hagen
- Expérience